GSK saw the highest growth of 107% in patent filings in March and 122% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 87% and grants by 122%. GlobalData’s DataBook provides a comprehensive analysis of GSK‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

GSK has been focused on protecting inventions in United States(US) with 52 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 24% filings and 25% grants. The United States(US), European Patent Office(EPO), Japan(JP), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where GSK is filings its patents. Among the top granted patent authorities, GSK has 25% of its grants in United States(US), 11% in European Patent Office(EPO) and 8% in Japan(JP).

F. Hoffmann-La Roche could be the strongest competitor for GSK

Patents related to nanomedicine and rare diseases lead GSK's portfolio

GSK has the highest number of patents in nanomedicine followed by, rare diseases and climate change. For nanomedicine, nearly 30% of patents were filed and 19% of patents were granted in Q1 2024.

Human immunodeficiency virus (hiv) infections (aids) related patents lead GSK portfolio followed by respiratory syncytial virus (rsv) infections, and ovarian cancer

GSK has highest number of patents in human immunodeficiency virus (hiv) infections (aids) followed by respiratory syncytial virus (rsv) infections, ovarian cancer, epstein–barr virus (hhv-4) infections, and herpes zoster (shingles). For human immunodeficiency virus (hiv) infections (aids), nearly 8% of patents were filed and 9% of patents were granted in Q1 2024.

For comprehensive analysis of GSK's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.